Vimarsana
Biggest News Aggregation in the World

About Neogenomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from About Neogenomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In About Neogenomics Today - Breaking & Trending Today

NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences - Vimarsana News

NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences

Published: March 2, 2022

02.03.2022 - FT MYERS, FL / ACCESSWIRE / March 2, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that senior management will be participating in ...

Source: wallstreet-online.de
Related Topics:
Fort MyersUnited StatesNorth CarolinaUnited KingdomResearch Triangle ParkSan DiegoAliso ViejoCharlie EidsonDoug BrownNeogenomics IncCompany Pharma Services DivisionWhile The CompanyCompany Annual Report On FormCompany Overview PresentationCorporate DevelopmentAbout NeogenomicsPharma Services DivisionPrivacy PracticesTriangle ParkPrivate Securities Litigation Reform ActAnnual ReportInvestor Relations
NeoGenomics To Participate In The Stephens Annual Investment Conference 2021 - Vimarsana News

NeoGenomics To Participate In The Stephens Annual Investment Conference 2021

Published: November 30, 2021

30.11.2021 - FT. MYERS, FL / ACCESSWIRE / November 30, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Mark Mallon, Chief Executive Officer, ...

Source: wallstreet-online.de
Related Topics:
Fort MyersUnited StatesNorth CarolinaUnited KingdomResearch Triangle ParkSan DiegoAliso ViejoCharlie EidsonDoug BrownCompany Annual Report On FormWhile The CompanyCorporate DevelopmentNeogenomics IncCompany Pharma Services DivisionAbout NeogenomicsPharma Services DivisionPrivacy PracticesTriangle ParkPrivate Securities Litigation Reform ActAnnual ReportInvestor Relations